# Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs

> **NCT05630365** · NA · COMPLETED · sponsor: **Abbott Rapid Dx** · enrollment: 1129 (actual)

## Conditions studied

- COVID-19
- Influenza A
- Influenza Type B

## Interventions

- **DIAGNOSTIC_TEST:** Panbio™

## Key facts

- **NCT ID:** NCT05630365
- **Lead sponsor:** Abbott Rapid Dx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-15
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 1129 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05630365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05630365, "Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05630365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*